Original Article
Comparison of contrast sensitivity in β-thalassemia patients treated by deferoxamine or deferasirox
Comparación de la sensibilidad de contraste en los pacientes con β-Talasemia tratados con Deferoxamina o Deferasirox
Azam Ghazanfaria, Ebrahim Jafarzadehpourb, Samira Heydarianc,
, Kiumars Nowroozpoor Dailamid, Hosein Karamie
Corresponding author
opt_heydarian@yahoo.com
Corresponding author at: Department of Optometry, School of Paramedical Science, Mashhad University of Medical Sciences, Mashhad, Iran.
Corresponding author at: Department of Optometry, School of Paramedical Science, Mashhad University of Medical Sciences, Mashhad, Iran.
a Department of Optometry, Iran University of Medical Sciences, Tehran, Iran
b Department of Optometry, Rehabilitation Faculty, Iran University of Medical Sciences, Tehran, Iran
c Department of Optometry, School of Paramedical Science, Mashhad University of Medical Sciences, Mashhad, Iran
d Department of Ophthalmology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
e Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Read
9788
Timeswas read the article
3808
Total PDF
5980
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 20 | 9 | 29 |
| 2025 5 | 60 | 60 | 120 |
| 2025 4 | 58 | 44 | 102 |
| 2025 3 | 68 | 51 | 119 |
| 2025 2 | 77 | 59 | 136 |
| 2025 1 | 34 | 50 | 84 |
| 2024 12 | 61 | 58 | 119 |
| 2024 11 | 43 | 67 | 110 |
| 2024 10 | 40 | 87 | 127 |
| 2024 9 | 54 | 48 | 102 |
| 2024 8 | 64 | 69 | 133 |
| 2024 7 | 64 | 46 | 110 |
| 2024 6 | 53 | 55 | 108 |
| 2024 5 | 48 | 71 | 119 |
| 2024 4 | 51 | 61 | 112 |
| 2024 3 | 45 | 45 | 90 |
| 2024 2 | 33 | 63 | 96 |
| 2024 1 | 53 | 67 | 120 |
| 2023 12 | 32 | 64 | 96 |
| 2023 11 | 58 | 66 | 124 |
| 2023 10 | 52 | 66 | 118 |
| 2023 9 | 51 | 68 | 119 |
| 2023 8 | 31 | 42 | 73 |
| 2023 7 | 41 | 49 | 90 |
| 2023 6 | 59 | 65 | 124 |
| 2023 5 | 55 | 54 | 109 |
| 2023 4 | 41 | 49 | 90 |
| 2023 3 | 47 | 56 | 103 |
| 2023 2 | 40 | 48 | 88 |
| 2023 1 | 49 | 56 | 105 |
| 2022 12 | 80 | 67 | 147 |
| 2022 11 | 43 | 49 | 92 |
| 2022 10 | 79 | 40 | 119 |
| 2022 9 | 57 | 39 | 96 |
| 2022 8 | 48 | 37 | 85 |
| 2022 7 | 51 | 36 | 87 |
| 2022 6 | 57 | 28 | 85 |
| 2022 5 | 75 | 23 | 98 |
| 2022 4 | 122 | 30 | 152 |
| 2022 3 | 99 | 39 | 138 |
| 2022 2 | 110 | 29 | 139 |
| 2022 1 | 88 | 28 | 116 |
| 2021 12 | 70 | 43 | 113 |
| 2021 11 | 50 | 42 | 92 |
| 2021 10 | 110 | 59 | 169 |
| 2021 9 | 63 | 47 | 110 |
| 2021 8 | 44 | 54 | 98 |
| 2021 7 | 46 | 44 | 90 |
| 2021 6 | 33 | 36 | 69 |
| 2021 5 | 47 | 53 | 100 |
| 2021 4 | 212 | 104 | 316 |
| 2021 3 | 111 | 48 | 159 |
| 2021 2 | 53 | 22 | 75 |
| 2021 1 | 55 | 38 | 93 |
| 2020 12 | 66 | 26 | 92 |
| 2020 11 | 66 | 35 | 101 |
| 2020 10 | 56 | 35 | 91 |
| 2020 9 | 61 | 40 | 101 |
| 2020 8 | 179 | 34 | 213 |
| 2020 7 | 86 | 44 | 130 |
| 2020 6 | 55 | 36 | 91 |
| 2020 5 | 59 | 30 | 89 |
| 2020 4 | 65 | 35 | 100 |
| 2020 3 | 66 | 20 | 86 |
| 2020 2 | 71 | 18 | 89 |
| 2020 1 | 84 | 27 | 111 |
| 2019 12 | 85 | 30 | 115 |
| 2019 11 | 101 | 39 | 140 |
| 2019 10 | 365 | 55 | 420 |
| 2019 9 | 305 | 73 | 378 |
| 2019 8 | 261 | 47 | 308 |
| 2019 7 | 307 | 58 | 365 |
| 2019 6 | 30 | 48 | 78 |
| 2019 5 | 27 | 27 | 54 |
| 2019 4 | 30 | 30 | 60 |
| 2019 3 | 30 | 22 | 52 |
| 2019 2 | 37 | 26 | 63 |
| 2019 1 | 41 | 43 | 84 |
| 2018 12 | 53 | 35 | 88 |
| 2018 11 | 47 | 42 | 89 |
| 2018 10 | 51 | 38 | 89 |
| 2018 9 | 10 | 13 | 23 |
| 2018 7 | 1 | 0 | 1 |
| 2018 5 | 0 | 13 | 13 |
| 2018 4 | 0 | 24 | 24 |
| 2018 3 | 0 | 37 | 37 |
Show all
